CytomX Therapeutics, Inc. (CTMX)
4.405
+0.18
(+4.38%)
USD |
NASDAQ |
Mar 26, 15:06
CytomX Therapeutics Cash from Investing (Quarterly) : -14.42M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Rigel Pharmaceuticals, Inc. | -25.36M |
| REGENXBIO, Inc. | 37.54M |
| Ovid Therapeutics, Inc. | -72.06M |
| Olema Pharmaceuticals, Inc. | -162.18M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.24M |
| Cash from Financing (Quarterly) | 16.64M |
| Free Cash Flow | -75.81M |
| Free Cash Flow Per Share (Quarterly) | -0.1378 |
| Free Cash Flow to Equity (Quarterly) | -22.09M |
| Free Cash Flow to Firm (Quarterly) | -23.44M |
| Free Cash Flow Yield | -12.48% |